Acceptability of a bioadhesive Nonoxynol-9 gel delivered by an applicator as a rectal microbicide

Sexually Transmitted Diseases

Volumn 26, Issue 10, 1999, Pages 572-578

  Gross, Michael ^a   Celum, Connie L ^b   Tabet, Stephen R ^b   Kelly, Clifton W ^c   Coletti, Anne S ^d   Chesney, Margaret A ^e  

^a ABT ASSOCIATES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Hemosol (USA) Inc   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANTAGE 24; NONOXINOL 9; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; RECTUM DISEASE; SENSATION; SEXUALLY TRANSMITTED DISEASE;

ADULT; ANTI-INFECTIVE AGENTS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; NONOXYNOL; PATIENT COMPLIANCE; QUESTIONNAIRES; RECTUM; SEXUAL BEHAVIOR;

EID: 0032693652     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199911000-00006     Document Type: Article

References (26)

1. Samuel MC, Hessol N, Shiboski S, Engel RR, Speed TP, Winkelstein W Jr. Factors associated with human immunodeficiency virus seroconversion in homosexual men in three San Francisco cohort studies, 1984-1989. J AIDS 1993;6:303-312.
2. Buchbinder SP, Douglas JM, McKirnan DJ, Judson FN, Katz M, MacQueen K. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the U.S.: Risk behavior, seroincidence, and willingness to participate. J Infect Dis 1996;174:954-961.
3. Remien RH, Wagner G, Carballo-Dieguez A, Dolezal C. HAART, attitudes, and risk behavior among serodiscordant male couples. 12th World AIDS Conference Record. Geneva, Switzerland, June 28-July 3 1998. Abstract 643/14136.
4. Wood RW, Goldbaum GM, Okita K. Changing sexual behavior in men who have sex with men seen at a Seattle HIV testing site, 1988-1997. 12th World AIDS Conference Record. Geneva, Switzerland, June 28-July 3 1998. Abstract 23102.
5. Schechter M, Strathdee SA, Martindale SL, et al. Evidence of elevated HIV incidence and relapse to unsafe sex among young men having sex with men (MSM) in Vancouver Canada. 12th World AIDS Conference Record. Geneva, Switzerland, June 28-July 3 1998. Abstract 23118.
6. Remien RH, Halkitis PN, O'Leary A, Hays R. Perceptions, attitudes, and sexual risk among HIV-positive men with undetectable plasma viral loads 12th World AIDS Conference Record. Geneva, Switzerland, June 28-July 3 1998. Abstract 23389.
7. Kippax S, Song A, Knox S, et al. Changes in anal sexual practice among Australian gay men 1986-1997: a rational response to HIV? 12th World AIDS Conference Record. Geneva, Switzerland, June 28-July 3 1998. Abstract 23413.
8. Ekstrand M, Stall R, Paul J, et al. Increasing rates of unprotected anal intercourse among San Francisco gay men include high UAI rates with a partner of unknown or different serostatus. 12th World AIDS Conference Record. Geneva, Switzerland, June 28-July 3 1998. Abstract 23116.
9. Van den Hoek JAR, van Griensven GJP, Coutinho RA. Increase in unsafe homosexual behavior [letter]. Lancet 1990;336:179-180.
10. Evans BG, Catchpole MA, Heptonstall J, et al. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. BMJ 1993;306:426-428.
11. Padian N, Marquis L, Francis DP, et al. Male to female transmission of human immunodeficiency virus. JAMA 1987;257:640-644.
12. Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman transmission of HIV: Longitudinal study of 343 steady partners of infected men. J AIDS 1993;6:497-502.
13. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997;146:350-357.
14. Brown V, Weissman G. Women and men injection drug users: an updated look at gender differences and risk factors. In: Brown B, Beschner G, eds. Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood Press, 1993:173-194.
15. Mayer KH, Koblin B, Marmor M, Donnell D, Chiasson MA, Flanigan T. Contraceptive practices among US women at increased risk for HIV acquisition. XI International Conference on AIDS, July 8-11, 1996, Vancouver, Canada, 2:333. Abstract Th.C.4510.
16. Elias C, Heise L. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994;8;1-9.
17. Stein ZA. More on women and the prevention of HIV infection. AJPH 1995;85:1485-1487.
18. Vermund SH. Casual sex and HIV transmission. AJPH 1995;85;1488-1489.
19. Stein Z. HIV prevention: an update on the status of methods women can use. AJPH 1993;83:1379-1382.
20. Gross M, Buchbinder SP, Celum C, et al. Rectal microbicides for U.S. gay men: are clinical trials needed? Are they feasible? Sex Transm Dis 1998;25(6):296-300.
21. Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Weir SS, Wong EL. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339: 504-510.
22. Kreiss J, Ngugi E, Holmes K. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992;268:477-482.
23. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991;18:176-179.
24. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993;4:165-170.
25. Van Damme L, Chandeying V, Ramjee V. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. 12 World AIDS Conference Record, Geneva, Switzerland, June 28-July 3 1998. Abstract 33145.
26. Tabet S, Surawicz C, Horton S, et al. Safety and toxicity of nonoxynol-9 gel for possible use as a rectal microbicide. Sex Transm Dis, 1999;26:564-571.